Pelthos Therapeutics Inc. (PTHS)

ASE – Real Time Price. Currency in USD

29.03

-0.18 (-0.62%)

At close: Jun 26, 2026, 4:00 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

17M

Cost of goods sold

-6M

Gross Profit

11M

Operating expenses (excl. COGS)

-43M

-8M

-7M

-2M

Operating Income

-32M

-8M

-7M

-2M

Non-operating income, total

-18M

-384K

-519K

-140K

Pretax income

-51M

-8M

-7M

-2M

Equity in earnings

Taxes

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-43M

-8M

-7M

-2M

Pelthos Therapeutics Inc. (PTHS)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Pelthos Therapeutics Inc. (PTHS)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Pelthos Therapeutics Inc. (PTHS)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Pelthos Therapeutics Inc. (PTHS)

Income Statement (Annual)

Income Statement (Annual)